Fava, G
Wegovy (semaglutide injection, 2.4 mg) is FDA-approved for chronic weight management in adults with obesity, or overweight adults with at least one weight-related health condition such as high blood pressure, type 2 diabetes, or high cholesterol
Like with many medications, though, it can cause some side effects, including sulfur burps, which can be a frequent and frustrating issue for those on their weight loss journey
Doses transfer 1:1: someone on 10 mg of Mounjaro can switch to 10 mg of compounded tirzepatide on their next scheduled injection without dose adjustment
Reduces Inflammation- SAG modulates inflammation by regulating cytokine production, which can benefit conditions like arthritis, asthma, and other inflammatory disorders
It also disburses energy at cellular level